Hereditary spherocytosis diagnostic study of choice

Diagnostic Criteria

• The diagnosis of hereditary spherocytosis can be based on the physical examination, complete red cell count, recticulocyte count, medical history and specific tests, preferentially, the EMA (eosin-5-maleimide binding) test and AGLT (acidified glycerol lysis time).
• The diagnosis can be made at any age, including the neonatal period from day of birth.
• The diagnostic guidelines of hereditary spherocytosis from the British Committee for Standards in hematology do not recommend any additional tests for patients with classical clinical features and laboratory data.
• The eosin-5-maleimide (EMA) binding test has high sensitivity (92–93%) and specificity (99%) for hereditary spherocytosis, although a positive test can also be obtained in patients affected by related conditions, such as congenital dyserythropoietic anemia type II (CDA II)
• Other tests, such as the osmotic fragility (OF) test, acidified glycerol lysis test (AGLT) and the pink test, exhibit lower sensitivity compared to the EMA test (68%, 61% and 91%, respectively).
• Ektacytometry is a highly sensitive test of membrane deformability.

Simple Diagnostic Criteria to evoke the Diagnosis of Hereditary Spherocytosis

Clinical Parameters	pallor, splenomegaly, inconstant jaundice
Biological paraneters & erythrocyte indices	dec Hb, inc MCHC, inc %hyperdense cells, inc reticulocytes
Blood smear	Spherocytes (may be absent)
Signs of hemolysis	inc free bilirubin, dec haptoglobin, inc reticulocytes
Erythrocyte coombs test	negative

Specific Biological Examinations for the Diagnosis of Hereditary Spherocytosis

Tests	Principle/feasibility	Sensitivity/Specificity
Osmotic resistance	hemolysis test/routime examination	66%/low
Pink test	hemolysis test/simple test time-out test <3 hours	96%/79-94%
AGLT	Hemolysis test time of test >3 hours	81%/95%
Ektacytometry in osmolar gradient	study of deformity of RBCs single laboratory in France test execution time:24 hours	reference exam
Flow cytometry	labeling of RBCs with eosin 5 maleimide/not available on routine basis test run time >48 h	Being evaluated

1. Newly diagnosed patients with a family history of HS, typical clinical features and laboratory investigations (spherocytes, raised mean corpuscular haemoglobin concentration [MCHC], increase in reticulocytes) do not require any additional tests (grade 1 recommendation, grade A evidence).
2.  If the diagnosis is equivocal, a screening test with high predictive value for HS is helpful. The recommended screening tests are the cryohaemolysis test and EMA binding (grade 1 recommendation, grade A evidence). (Confirmation).
3.  Gel electrophoresis analysis of erythrocyte membranes is the method of choice for diagnosis of atypical cases."Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update - Bolton‐Maggs - 2012 - British Journal of Haematology - Wiley Online Library".